Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

Recruiting now

Conditions studied: Early-stage Breast Cancer, Breast Carcinoma in Situ, Breast Neoplasms

In brief

This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment method. We aim to assess short and long-term patient outcomes associated with IORT, including perioperative complications, local and distance disease recurrences, as well as disease-free survival and overall survival.

Key facts

Study ID

NCT04603209

Run by

Saint John's Cancer Institute

People needed

1000

Starts

2018-10-03

Expected to finish

2028-10-03

Last updated by the study team

2024-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical stage Tis, T1, or T2(≤ 3cm), N0, M0 (AJCC Classification)
• Unifocal Disease
• Candidate for breast-conserving surgery
• Recommended treatment by multidisciplinary team

You may not qualify if…

• Clinical stage T3-4, N1-3, M1
• Multifocal disease

Where it is running

• John Wayne Cancer Institute, Providence Saint John's Health Center — Santa Monica, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.